Month: September 2020

NEWPORT NEWS, Va., Sept. 08, 2020 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE: HII) announced today two new appointments within their law department. Jeffrey Bauer was recently promoted to corporate vice president of litigation and investigations. Paul C. Harris will join the HII legal team as corporate vice president and chief compliance and privacy officer, effective Sept. 8, 2020. Bauer and Harris both will report to Executive Vice President and Chief Legal Officer Chad Boudreaux.Bauer joined HII in 2012 as senior counsel, litigation and investigations. In his new role, he will continue to provide strategic leadership over HII’s litigation matters as well as its investigations process, including internal investigations and government regulatory actions. Prior to joining HII, Bauer served as a trial attorney in the...

LOUDON, Tenn., Sept. 08, 2020 (GLOBE NEWSWIRE) — Malibu Boats, LLC, the leading pioneer of modern wakesurfing technology, including the standard-setting Surf Gate system, reported that the Court entered a favorable claim construction ruling in Malibu’s ongoing patent litigation against Skier’s Choice. In that litigation, Malibu is asserting infringement by certain Skier’s Choice Supra and Moomba branded boats.Today, only days after the Court’s ruling, Malibu announced that MB Sports, Inc. entered into a license agreement with Malibu that includes MB paying a one-time payment and future royalties to Malibu. Malibu CEO Jack Springer said, “The boating industry continues to show respect for Malibu’s innovations. Today, over twenty brands directly or indirectly license our IP, and in the towboat manufacturing segment, every significant...

COPENHAGEN, Denmark, Sept. 08, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that uses its novel TransCon technologies to address unmet medical needs, announced today the submission of a MAA to the EMA seeking approval for TransCon hGH (lonapegsomatropin), an investigational long-acting once-weekly prodrug of somatropin (human growth hormone or hGH), for the treatment of pediatric patients who are diagnosed with growth hormone deficiency (GHD).“This MAA submission, which follows the approval of our Paediatric Investigation Plan (PIP) from EMA, is an important next step for extending the global reach of TransCon hGH,” said Dana Pizzuti, M.D., Ascendis Pharma’s Senior Vice President of Development Operations. “If approved, TransCon hGH could provide clinicians and patients with a once-weekly...

SANTA ANA, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Spectrum Group International, Inc. (OTCPK:SPGZ) (“SGI” or the “Company”), an integrated network of leading companies concentrating on numismatics (coins) and paper currency, announced today the commencement of a self-tender offer (the “Offer”) to purchase for cash up to 4,000 common shares, par value $0.01 of the Company (the “Common Shares”). The purchase price is $625 per Common Share.The Offer will expire at 5:00 pm, Eastern Time, on Tuesday, October 6, 2020, unless extended by SGI (the “Expiration Time”). Tenders of the Common Shares must be made prior to the Expiration Time and may not be withdrawn. However, if the Expiration Time is extended and closing of the Offer has not occurred by November 7, 2020, shareholders may withdraw their previously tendered Common Shares.Participation...

PHILADELPHIA, PA, Sept. 08, 2020 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN) and INSU Acquisition Corp. II (NASDAQ:INAQU) today announced that INSU Acquisition Corp. II (the “Company”), a blank-check company sponsored by Cohen & Company and formed for the purpose of acquiring or merging with one or more businesses or entities in the insurance industry, completed its initial public offering of 23,000,000 units at a price of $10.00 per unit, which includes 3,000,000 units issued pursuant to the underwriters’ over-allotment option, for gross proceeds to the Company of $230,000,000. The Company’s units began trading on September 3, 2020 on the Nasdaq Capital Market under the symbol “INAQU”. Each unit issued in the offering consists of one share of the Company’s Class A common stock and one-third...

MIAMI, Sept. 08, 2020 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI), (Intermex) a leading money remittance services company, today announced that it set an all-time high for one month sales in August delivering 2,999,869 remittances, up 13.4% over August 2019. Contributing to this record performance were all-time high transactions to countries including Mexico, Guatemala, and Honduras.“We are extremely proud of the dedication and performance of our agent partners and Intermex employees to deliver these critical remittances from the United States and Canada to individuals across Latin America and Africa,” said Chairman, CEO and President, Bob Lisy. “Our ability to attract customers is a testament to Intermex’s focused, high quality agent network strategy, and our ability to provide high reliability and service...

CARLSBAD, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that Pat Miles, Chief Executive Officer, will participate in the following virtual fireside chats:Morgan Stanley’s 18th Annual Global Healthcare Conference on September 18, 2020, at 11:00 A.M. ET.Lake Street Capital Markets 4th Annual Best Ideas Growth Conference on September 17, 2020, at 4:00 P.M. ET.Jeff Black, Chief Financial Officer, will virtually present at the H.C. Wainwright Annual Healthcare Conference on September 15, 2020, at 1:00 P.M. ET.Management will also participate one-on-one meetings with registered conference attendees. If available, a live audio webcast of each of the...

Five patients treated in first cohort of Phase 1 clinical trial evaluating the safety and tolerability of FX201; Drug Monitoring Committee (DMC) supported the initiation of the next dosing cohortBURLINGTON, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the treatment of the first patient in the second cohort of the Phase 1 dose-escalation trial evaluating the safety and tolerability of FX201, an investigational, intra-articular, IL-1Ra gene therapy product candidate being developed for the treatment of osteoarthritis (OA).“We are encouraged by the continued progress of the single ascending dose study of FX201,” said Michael Clayman, MD, President and Chief Executive Officer of Flexion Therapeutics. “OA is a painful, progressive disease which has no cure and although it remains...

VICTOR, N.Y., Sept. 08, 2020 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, reiterates that Garth Hankinson, chief financial officer, will present virtually at the 2020 Barclays Global Consumer Staples Conference on Wednesday, September 9, 2020. The presentation is scheduled to begin at 11:20 a.m. ET and is expected to cover the company’s strategic business initiatives, financial metrics, operating performance, and recent product portfolio performance, as well as outlook for the future, including an update on the pending Wine and Spirits transactions.A live, listen-only webcast of the virtual presentation will be available on the company’s website, which can be accessed at www.cbrands.com, under the Investors/Events & Presentations section. When the presentation begins,...